Peter H. Dorff

1.1k total citations
18 papers, 460 citations indexed

About

Peter H. Dorff is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Peter H. Dorff has authored 18 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Peter H. Dorff's work include Chemical Synthesis and Analysis (4 papers), Synthesis and Biological Evaluation (4 papers) and Cancer therapeutics and mechanisms (3 papers). Peter H. Dorff is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Synthesis and Biological Evaluation (4 papers) and Cancer therapeutics and mechanisms (3 papers). Peter H. Dorff collaborates with scholars based in United States. Peter H. Dorff's co-authors include James R. Hauske, Mark P. Wentland, Ravi S. Garigipati, James Rake, Robert B. Perni, M. D. GRUETT, Steven W. Goldstein, Michael Reuman, Baldev Singh and George Y. Lesher and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Tetrahedron Letters.

In The Last Decade

Peter H. Dorff

18 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter H. Dorff United States 13 302 268 52 37 31 18 460
William A. Metz United States 13 262 0.9× 172 0.6× 53 1.0× 24 0.6× 20 0.6× 22 424
Kingsley H. Nelson United States 6 257 0.9× 195 0.7× 31 0.6× 33 0.9× 14 0.5× 7 349
Lyndon A. M. Cornelius United States 11 347 1.1× 197 0.7× 56 1.1× 26 0.7× 26 0.8× 19 563
Katsuji Aikawa Japan 11 257 0.9× 159 0.6× 91 1.8× 20 0.5× 10 0.3× 13 488
Manav Malhotra India 13 305 1.0× 135 0.5× 56 1.1× 37 1.0× 15 0.5× 38 473
Michael Arlt Germany 9 414 1.4× 270 1.0× 28 0.5× 21 0.6× 15 0.5× 12 541
John W. Butcher United States 11 199 0.7× 180 0.7× 33 0.6× 48 1.3× 23 0.7× 14 407
Ricardo A. M. Serafim Brazil 12 332 1.1× 188 0.7× 46 0.9× 21 0.6× 14 0.5× 21 539
Venkatram R. Mereddy United States 14 205 0.7× 181 0.7× 53 1.0× 35 0.9× 21 0.7× 31 405

Countries citing papers authored by Peter H. Dorff

Since Specialization
Citations

This map shows the geographic impact of Peter H. Dorff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Dorff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Dorff more than expected).

Fields of papers citing papers by Peter H. Dorff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter H. Dorff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Dorff. The network helps show where Peter H. Dorff may publish in the future.

Co-authorship network of co-authors of Peter H. Dorff

This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. Dorff. A scholar is included among the top collaborators of Peter H. Dorff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. Dorff. Peter H. Dorff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kohrt, Jeffrey T., Peter H. Dorff, Steven V. O’Neil, et al.. (2021). Application of Flow and Biocatalytic Transaminase Technology for the Synthesis of a 1-Oxa-8-azaspiro[4.5]decan-3-amine. Organic Process Research & Development. 26(3). 616–623. 9 indexed citations
2.
Li, Bryan, et al.. (2019). Deprotection of N-Boc Groups under Continuous-Flow High-Temperature Conditions. The Journal of Organic Chemistry. 84(8). 4846–4855. 34 indexed citations
3.
Gu, Chungang, Charles S. Elmore, Lin Jian-rong, et al.. (2012). Metabolism of a G Protein-Coupled Receptor Modulator, Including Two Major 1,2,4-Oxadiazole Ring-Opened Metabolites and a Rearranged Cysteine-Piperazine Adduct. Drug Metabolism and Disposition. 40(6). 1151–1163. 13 indexed citations
4.
Efremov, Ivan, F.F. Vajdos, Kris A. Borzilleri, et al.. (2012). Discovery and Optimization of a Novel Spiropyrrolidine Inhibitor of β-Secretase (BACE1) through Fragment-Based Drug Design. Journal of Medicinal Chemistry. 55(21). 9069–9088. 50 indexed citations
5.
Kath, John C., William H. Brissette, Matthew F. Brown, et al.. (2004). Potent small molecule CCR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 14(9). 2169–2173. 17 indexed citations
6.
Dorff, Peter H. & Ravi S. Garigipati. (2001). Novel solid-phase preparation of 2,6,9-trisubstituted purines for combinatorial library generation. Tetrahedron Letters. 42(15). 2771–2773. 27 indexed citations
7.
Dorff, Peter H., G. Chiu, Steven W. Goldstein, & B. Paul Morgan. (1998). Solid phase synthesis of phosphinopeptoids as transition state analog inhibitors. Tetrahedron Letters. 39(21). 3375–3378. 20 indexed citations
8.
Wentland, Mark P., Robert B. Perni, Peter H. Dorff, et al.. (1997). Antiviral properties of 3-quinolinecarboxamides: a series of novel non-nucleoside antiherpetic agents.. PubMed. 15(1). 25–38. 7 indexed citations
9.
Reuman, Michael, Sol J. Daum, Baldev Singh, et al.. (1995). Synthesis and Antibacterial Activity of Some Novel 1-Substituted 1,4-Dihydro-4-oxo-7-pyridinyl-3-quinolinecarboxylic Acids. Potent Antistaphylococcal Agents. Journal of Medicinal Chemistry. 38(14). 2531–2540. 21 indexed citations
10.
Wentland, Mark P., J. Andrew Carlson, Peter H. Dorff, et al.. (1995). Cyclic Variations of 3-Quinolinecarboxamides and Effects on Antiherpetic Activity. Journal of Medicinal Chemistry. 38(14). 2541–2545. 4 indexed citations
11.
Hauske, James R. & Peter H. Dorff. (1995). A solid phase CBZ chloride equivalent — a new matrix specific linker. Tetrahedron Letters. 36(10). 1589–1592. 89 indexed citations
13.
Wentland, Mark P., Robert B. Perni, Peter H. Dorff, et al.. (1993). 3-Quinolinecarboxamides. A series of novel orally-active antiherpetic agents. Journal of Medicinal Chemistry. 36(11). 1580–1596. 31 indexed citations
14.
Wentland, Mark P., George Y. Lesher, Michael Reuman, et al.. (1993). Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and related derivatives. Journal of Medicinal Chemistry. 36(19). 2801–2809. 58 indexed citations
15.
Wentland, Mark P., Robert B. Perni, Peter H. Dorff, et al.. (1993). ChemInform Abstract: 3‐Quinolinecarboxamides. A Series of Novel Orally‐Active Antiherpetic Agents.. ChemInform. 24(35). 1 indexed citations
16.
Hauske, James R., et al.. (1992). Design and synthesis of novel FKBP inhibitors. Journal of Medicinal Chemistry. 35(23). 4284–4296. 24 indexed citations
17.
Hauske, James R., et al.. (1992). Preparation and reactions of chiral propargylic amines. Tetrahedron Letters. 33(26). 3715–3716. 35 indexed citations
18.
Wentland, Mark P., Robert B. Perni, Peter H. Dorff, & James Rake. (1988). Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative. Journal of Medicinal Chemistry. 31(9). 1694–1697. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026